The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment

Por Skinner-Adams, Tina S., Butterworth, Alice S., Porter, Kimberly A., D'Amico, Ronald, Sawe, Fred, Shaffer, Doug, Siika, Abraham, Hosseinipour, Mina C., Stringer, Elizabeth, Currier, Judith S., Chipato, Tsungai, Salata, Robert, Lockman, Shahin, Eron, Joseph J., Meshnick, Steven R., McCarthy, James S.
Publicado em 2012

Safety and efficacy of ombitasvir – 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens

Por Eron, Joseph J, Lalezari, Jay, Slim, Jihad, Gathe, Joseph, Ruane, Peter J, Wang, Chia, Elion, Richard, Blick, Gary, Khatri, Amit, Hu, Yiran B, Gibbons, Krystal, Fredrick, Linda, Co, Melannie, D'Amico, Ronald, Da Silva-Tillmann, Barbara, Trinh, Roger, Sulkowski, Mark S
Publicado no J Int AIDS Soc (2014)

HIV-1 Protease Inhibitors and Clinical Malaria: a Secondary Analysis of the AIDS Clinical Trials Group A5208 Study

Por Porter, Kimberly A., Cole, Stephen R., Eron, Joseph J., Zheng, Yu, Hughes, Michael D., Lockman, Shahin, Poole, Charles, Skinner-Adams, Tina S., Hosseinipour, Mina, Shaffer, Doug, D'Amico, Ronald, Sawe, Frederick K., Siika, Abraham, Stringer, Elizabeth, Currier, Judith S., Chipato, Tsungai, Salata, Robert, McCarthy, James S., Meshnick, Steven R.
Publicado em 2012